BTLA antibodies
MYPI2025005290A0Undetermined Publication Date: 2021-12-11OXFORD UNIVERSITY INNOVATION LTD +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025005290
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-06-11
- Filing Date
- 2021-06-11
- Publication Date
- 2021-12-11
Abstract
This invention relates generally to antibodies that bind to human B and T lymphocyte attenuator (BTLA) and uses thereof. More specifically, the invention relates to agonistic antibodies that bind human BTLA and modulate its activity, and their use in treating inflammatory, autoimmune and proliferative diseases and disorders. Suitably, the antibodies also possess an Fc modification that enhances signalling through FcɣR2B.
Need to check novelty before this filing date? Find Prior Art
